Outcomes of Allogeneic Transplantation with Clofarabine and Post-Transplant Cyclophosphamide-Based Conditioning in Patients with Very High-Risk Acute Myeloid Leukemia

被引:0
|
作者
Garcia, Lucia Castilla [1 ]
Bailen, Rebeca [1 ]
Luna, Ignacio Alberto Gomez Centurion [1 ]
Fernandez-Caldas, Paula [2 ]
De Tena, Pablo Silva [1 ]
Martinez-Laperche, Carolina [3 ,4 ]
Anguita, Javier [5 ]
Garcia-Sanz, Ramon [5 ]
Kwon, Mi [5 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Hematol Dept, Madrid, Spain
[3] Hosp Univ Gregorio Maranon, Dept Anesthesiol, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria, Madrid, Spain
[5] Gen Univ Hosp Gregorio Maranon, Madrid, Spain
关键词
D O I
10.1182/blood-2024-210237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4889 / 4890
页数:2
相关论文
共 50 条
  • [31] CLOFARABINE AS BRIDGE TO TRANSPLANTATION IN PATIENTS WITH HIGH RISK RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
    Orciuolo, E.
    Buda, G.
    Benedetti, E.
    Caracciolo, F.
    Iovino, L.
    Rousseau, M.
    Galimberti, S.
    Favre, C.
    Petrini, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S550 - S550
  • [32] Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients
    Lucia Brunello
    Roberto Passera
    Chiara Maria Dellacasa
    Luisa Giaccone
    Ernesta Audisio
    Dario Ferrero
    Stefano D’Ardia
    Bernardino Allione
    Semra Aydin
    Moreno Festuccia
    Giuseppe Lia
    Elena Crisà
    Enrico Maffini
    Sara Butera
    Alessandro Busca
    Benedetto Bruno
    Annals of Hematology, 2018, 97 : 2205 - 2215
  • [33] Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients
    Brunello, Lucia
    Passera, Roberto
    Dellacasa, Chiara Maria
    Giaccone, Luisa
    Audisio, Ernesta
    Ferrero, Dario
    D'Ardia, Stefano
    Allione, Bernardino
    Aydin, Semra
    Festuccia, Moreno
    Lia, Giuseppe
    Crisa, Elena
    Maffini, Enrico
    Butera, Sara
    Busca, Alessandro
    Bruno, Benedetto
    ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2205 - 2215
  • [34] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Chemnitz, Jens Marcus
    von Lilienfeld-Toal, Marie
    Holtick, Udo
    Theurich, Sebastian
    Shimabukuro-Vornhagen, Alexander
    Krause, Anke
    Brossart, Peter
    Hallek, Michael
    Scheid, Christof
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 47 - 55
  • [35] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Jens Marcus Chemnitz
    Marie von Lilienfeld-Toal
    Udo Holtick
    Sebastian Theurich
    Alexander Shimabukuro-Vornhagen
    Anke Krause
    Peter Brossart
    Michael Hallek
    Christof Scheid
    Annals of Hematology, 2012, 91 : 47 - 55
  • [36] Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia
    Srour, Samer A.
    Milton, Denai R.
    Bashey, Asad
    Karduss-Urueta, Amado
    Al Malki, Monzr M.
    Romee, Rizwan
    Solomon, Scott
    Nademanee, Auayporn
    Brown, Stacey
    Slade, Michael
    Perez, Rosendo
    Rondon, Gabriela
    Forman, Stephan J.
    Champlin, Richard E.
    Kebriaei, Partow
    Ciurea, Stefan O.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 318 - 324
  • [37] Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia
    Salas, Maria Queralt
    Prem, Shruti
    Atenafu, Eshetu G.
    Law, Arjun Datt
    Lam, Wilson
    Al-Shaibani, Zeyad
    Loach, David
    Kim, Dennis
    Michelis, Fotios, V
    Lipton, Jeffrey Howard
    Kumar, Rajat
    Mattsson, Jonas
    Viswabandya, Auro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (05) : 510 - 518
  • [38] Evaluation of allogeneic haematopoietic stem cell transplantation and pre- and post-transplant therapy in high-risk patients with chronic myeloid leukaemia
    Oyekunle, A.
    Klyuchnikov, E.
    Kroeger, N.
    Zabelina, T.
    Ayuk, F.
    Wolschke, C.
    Bernhardt, F.
    Mueller, I.
    Zander, A.
    Bacher, U.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S363 - S363
  • [39] Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia
    Cao, Junjie
    Xu, Xiaodong
    Lu, Ying
    Wang, Tiantian
    Chen, Dong
    Li, Shuangyue
    Liu, Xuhui
    Ye, Peipei
    Zheng, Zhong-zheng
    Pei, Renzhi
    HEMATOLOGY, 2023, 28 (01)
  • [40] T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION WITH ALEMTUZUMAB IS A VIABLE ALTERNATIVE TO POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Rojek, Alexandra
    Mortel, Mylove
    Artz, Andrew
    Larson, Richard
    Liu, Hongtao
    Nawas, Mariam
    Duvall, Adam
    Odenike, Toyosi
    Roloff, Gregory
    Stock, Wendy
    Bishop, Michael
    Kosuri, Satyajit
    BONE MARROW TRANSPLANTATION, 2024, 59 : 313 - 315